| |
| |
|
| Insider
Information: |
Driscoll Frederick W |
| Relationship: |
Director |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
308,152 |
|
|
Indirect Shares
|
2,000 |
|
|
| Direct
Value |
$968,267 |
|
|
|
Indirect Value
|
$520 |
|
|
| Total
Shares |
310,152 |
|
|
| Total
Value |
$968,787 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
1.0
|
| Percentage
Gain/Loss : |
 -62.1%
|
 67.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mateon Therapeutics Inc |
MATN |
President and CEO, Dir... |
2005-10-03 |
122,000 |
2005-10-03 |
2,000 |
Premium* |
|
|
Novavax Inc |
NVAX |
VP, CFO & Treasurer |
2011-08-09 |
20,000 |
2011-08-09 |
0 |
Premium* |
|
|
Flexion Therapeutics Inc |
FLXN |
Chief Financial Officer |
2021-11-19 |
0 |
2014-11-20 |
0 |
Premium* |
|
|
ImmunityBio, Inc |
IBRX |
Director |
2020-08-11 |
109,235 |
2017-09-18 |
0 |
Premium* |
|
|
MEI Pharma Inc |
MEIP |
Director |
2021-02-23 |
37,500 |
2019-12-19 |
0 |
Premium* |
|
|
Cellectar Bioscienc |
CLRB |
Director |
2021-09-03 |
19,417 |
2021-09-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FLXN |
Flexion Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-11-19 |
4 |
D |
$8.50 |
$260,780 |
D/D |
(30,680) |
0 |
0 |
- |
|
| CLRB |
Cellectar Bioscienc |
Director |
– • – |
2021-09-03 |
4 |
B |
$1.04 |
$20,244 |
D/D |
19,417 |
19,417 |
2.39 |
% |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Financial OfficerOfficer |
• – – |
2021-06-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,680 |
|
% |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
30,680 |
0 |
- |
|
| MEIP |
MEI Pharma Inc |
Director |
– • – |
2021-02-23 |
4 |
S |
$4.03 |
$100,625 |
D/D |
(25,000) |
37,500 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2020-08-11 |
4 |
S |
$9.98 |
$668,052 |
D/D |
(65,300) |
109,235 |
0 |
% |
|
| MEIP |
MEI Pharma Inc |
Director |
– • – |
2019-12-19 |
4 |
B |
$1.60 |
$100,000 |
D/D |
62,500 |
62,500 |
2.39 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
92,592 |
174,535 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2018-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
27,322 |
81,943 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Director |
– • – |
2017-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
54,621 |
54,621 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Financial Officer |
• – – |
2017-03-23 |
4 |
AS |
$23.00 |
$69,000 |
D/D |
(3,000) |
7,777 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Financial Officer |
• – – |
2017-03-23 |
4 |
OE |
$7.89 |
$23,658 |
D/D |
3,000 |
10,777 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Financial Officer |
• – – |
2016-12-20 |
4 |
A |
$9.01 |
$10,217 |
D/D |
1,134 |
10,531 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Financial Officer |
• – – |
2016-05-20 |
4 |
A |
$8.92 |
$8,590 |
D/D |
963 |
9,397 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Financial Officer |
• – – |
2016-05-17 |
4 |
B |
$9.87 |
$24,668 |
D/D |
2,500 |
8,434 |
2.74 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Financial Officer |
• – – |
2016-05-16 |
4 |
B |
$9.19 |
$22,972 |
D/D |
2,500 |
5,934 |
2.74 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Financial Officer |
• – – |
2015-05-20 |
4 |
A |
$11.91 |
$15,614 |
D/D |
1,311 |
2,754 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Chief Financial Officer |
• – – |
2014-11-20 |
4 |
A |
$11.91 |
$17,186 |
D/D |
1,443 |
1,443 |
0 |
- |
|
| NVAX |
Novavax Inc |
VP, CFO & Treasurer |
• – – |
2011-08-09 |
4 |
B |
$1.18 |
$23,600 |
D/D |
20,000 |
20,000 |
2.74 |
- |
|
| MATN |
Mateon Therapeutics Inc |
President and CEO |
• • – |
2005-10-03 |
4/A |
A |
$0.00 |
$0 |
D/D |
80,000 |
122,000 |
|
- |
|
| MATN |
Mateon Therapeutics Inc |
President and CEO |
• • – |
2005-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
122,000 |
|
- |
|
| MATN |
Mateon Therapeutics Inc |
President and CEO |
• • – |
2004-05-20 |
4/A |
B |
$7.31 |
$14,620 |
D/D |
2,000 |
40,000 |
2.81 |
- |
|
| MATN |
Mateon Therapeutics Inc |
President and CEO |
• • – |
2004-05-20 |
4 |
A |
$7.31 |
$14,620 |
D/D |
2,000 |
40,000 |
|
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
